What are the risks and benefits of administering milrinone through peripheral versus central venous access?
Abstract
Both peripheral and central venous access for milrinone administration present distinct risks and benefits, including differences in thrombosis, infection, and extravasation rates. Choosing the most appropriate route depends on patient context and procedural control.
Fields of Study & Subjects
Central Venous Catheters and Hemodialysis
Intravenous Infusion Technology and Safety
Heart Failure Treatment and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 3 February 2026